# Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)

> **NCT00681408** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Virginia** · enrollment: 41 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis
- Fatty Liver

## Interventions

- **DRUG:** Omega 3 Fish Oil supplements
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00681408
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2015-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00681408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00681408, "Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00681408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*